Chemoinformaics analysis of 4-(Rhamnosyloxy)phenylacetonitrile
| Molecular Weight | 279.292 | nRot | 3 |
| Heavy Atom Molecular Weight | 262.156 | nRig | 13 |
| Exact Molecular Weight | 279.111 | nRing | 2 |
| Solubility: LogS | -2.426 | nHRing | 1 |
| Solubility: LogP | 0.459 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 39.8255 |
| nHD | 3 | BPOL | 21.0965 |
| QED | 0.717 |
| Synth | 3.507 |
| Natural Product Likeliness | 1.243 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.322 |
| HIA | 0.8 |
| CACO-2 | -5.244 |
| MDCK | 0.0000309 |
| BBB | 0.143 |
| PPB | 0.587805 |
| VDSS | 0.846 |
| FU | 0.371925 |
| CYP1A2-inh | 0.153 |
| CYP1A2-sub | 0.089 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.132 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.807 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.176 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.11 |
| CL | 3.216 |
| T12 | 0.708 |
| hERG | 0.025 |
| Ames | 0.218 |
| ROA | 0.245 |
| SkinSen | 0.23 |
| Carcinogencity | 0.832 |
| EI | 0.458 |
| Respiratory | 0.934 |
| NR-Aromatase | 0.024 |
| Antiviral | Yes |
| Prediction | 0.838894 |